NCT05236114 - Tempus NSCLC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With NSCLC Using NGS Assays

Brief Title

Tempus NSCLC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With NSCLC Using NGS Assays

Protocol ID

NCT05236114

Brief Summary

Condition: Non-Small Cell Lung Cancer
Intervention: Other: Observation
Sponsor: Tempus Labs
Recruiting

Pub Date:

Friday, February 11, 2022 - 10:00am

Study URL:

https://clinicaltrials.gov/ct2/show/NCT05236114?term=genomics%20DNA&%3Brecrs=abc